Amyotrophic Lateral Sclerosis (ALS): Exploring Innovative and Personalized Therapeutic Pathways
Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive neurodegenerative disease that primarily targets the motor neurons in the brain and spinal cord. As these nerve cells die, people begin to have muscle weakness and difficulty with involuntary muscle functions such as speaking, breathing and swallowing. Life expectancy is estimated 3–5 years from symptom onset, however, there is substantial individual variation.